NCT00725322View on ClinicalTrials.gov

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Pain
Interventions
DRUG

Botulinum Toxin A

Subcutaneous injection of Botulinum Toxin Type A into the patient's scar tissue

DRUG

Placebo - Saline

Subcutaneous Saline injection given at site of scar neuroma

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00725322 - Subcutaneous Botulinum Toxin for Cutaneous Allodynia | Biotech Hunter | Biotech Hunter